Snowball logo
logo
PHRX

Pharmagen Inc

PHRX • OTCCE
$0.00001$0.00  (0%)
Estimate
Beta
-0.087
About the company
Ticker
PHRX
ISIN
US71715W1062
Country
United States of America
Sector (GICS)
Healthcare
Pharmagen, Inc. distributes specialty drugs to hospitals, acute care facilities, surgery centers, and other healthcare practitioners in the United States. The company sources and distributes specialty drugs, blood plasma derivatives, specialty products, vaccines, anti-infectives, and hard-to-find pharmaceuticals. It offers plasma derivatives for treating serious medical conditions, such as cancer, hemophilia, rheumatoid arthritis, multiple scleroses, blood disorders, hepatitis, and HIV; and specialty products for treating respiratory, oncology, cardiovascular, and hormonal syndromes. The company also manufactures and distributes health supplements, including Clotamin, a specialized over-the-counter multivitamin dietary supplement for patients on Warfarin. In addition, it sells traditional pharmaceuticals to its distribution customers, such as antibiotics, vaccines, and other oral and injectable pharmaceuticals; and specializes in the formulation of drugs. The company was formerly known as Sunpeaks Ventures, Inc. and changed its name to Pharmagen, Inc. in January 2013. Pharmagen, Inc. is based in Silver Spring, Maryland.

Frequently asked questions

What sector does Pharmagen Inc (PHRX) operate in?

Pharmagen Inc belongs to the Healthcare sector and operates in the Medical Distribution industry.

What is Pharmagen Inc (PHRX) current stock price?

As of the latest data, Pharmagen Inc stock price is $0.00, with a previous close of $0.00.

What is Pharmagen Inc (PHRX) current market capitalization?

Pharmagen Inc market cap is approximately 5.17 thousand.

Does Pharmagen Inc (PHRX) pay dividends?

No. Pharmagen Inc does not pay a dividend.

What is Pharmagen Inc (PHRX) beta (volatility) score?

Pharmagen Inc has a beta of -0.087, indicating lower volatility than the overall market.